Passive immunisation and post-exposure prophylaxis
Exam lens: USMLE / PLAB
References
In brief
A vaccine is a preparation of antigen that induces specific active immunity and immunological memory without causing the disease. Passive immunisation gives ready-made antibody (immunoglobulin, antitoxin, monoclonal) for immediate but short protection.
How it works: antigen, often with an adjuvant, primes B and T cells; a booster raises antibody and memory. Protection depends on vaccine type, host age and immune status, schedule and storage. Population effect: herd immunity. Clinical use: routine schedules, special groups, travel, and post-exposure prophylaxis.
Clinical key: know the type (live or inactivated decides contraindications and spacing), the true contraindications (anaphylaxis to a previous dose or component; live vaccines in pregnancy and severe immunodeficiency) and the post-exposure scheme for rabies, tetanus, hepatitis B, measles and varicella. Disease-specific vaccine detail is in topics 3-11; this topic is the general principle.
Definitions and history
Active immunisation: the host makes its own response (vaccine or natural infection). Passive immunisation: borrowed antibody; no memory.
Jenner used cowpox against smallpox in 1796; Pasteur's rabies vaccine followed in 1885. Smallpox eradication was certified in 1980. Wild poliovirus type 2 (declared eradicated 2015) and type 3 (2019) are gone; wild type 1 remains endemic only in Pakistan and Afghanistan.
WHO Expanded Programme on Immunization began in 1974; the current global plan is Immunization Agenda 2030.